ReproCELL USA Competitors and Similar CompaniesClear all

ReproCELL USA's competitors and similar companies include Shanghai Fudan-Zhangjiang Bio-Pharmaceutical, Ginkgo Bioworks Holdings, Poseida Therapeutics and Igenomix.

	ReproCELL USA ReproCELL USA (formerly BioServe Biotechnologies) is a company providing preclinical molecular services and research tools.	Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Shanghai Fudan-Zhangjiang Bio-Pharmaceutical is a company that manufactures biomedicine.	Ginkgo Bioworks Holdings Ginkgo Bioworks Holdings is a company that designs and develops genetic technology solutions.	Poseida Therapeutics Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics.	Igenomix Igenomix is a reproductive genetics company.
Founding Date	Founding Date 1989	Founding Date 1996	Founding Date 2020	Founding Date 2015	Founding Date 2012
Type	Type Subsidiary	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics	Tags Technology biotech genetics	Tags Healthcare biotech genetics	Tags Healthcare biotech genetics
Locations	Locations Beltsville, US HQ	Locations CN HQ	Locations Boston, US HQ	Locations San Diego, US HQ	Locations Paterna, ES HQ New Delhi, IN Marostica, IT Ciudad De México, MX Dubai, AE see more
Employees	Employees 632% decrease	Employees 921	Employees 1,2186% decrease	Employees 3111% decrease	Employees 320
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) $170.2m (FY, 2025)	Revenue (est.) $64.7m (FY, 2023)	Revenue (est.) N/A
Net income	Net income N/A	Net income N/A	Net income ($312.8m) (FY, 2025)	Net income ($123.4m) (FY, 2023)	Net income N/A
Funding
Total funding raised	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 789.1m	Total funding raised $ 336.5m	Total funding raised N/A